MARKET

MRVI

MRVI

Maravai Lifesciences Holdings, Inc.
NASDAQ
2.860
-0.230
-7.44%
After Hours: 2.838 -0.022 -0.78% 19:15 03/27 EDT
OPEN
3.060
PREV CLOSE
3.090
HIGH
3.080
LOW
2.845
VOLUME
2.41M
TURNOVER
--
52 WEEK HIGH
4.105
52 WEEK LOW
1.665
MARKET CAP
735.21M
P/E (TTM)
-3.1571
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MRVI last week (0316-0320)?
Weekly Report · 6d ago
Weekly Report: what happened at MRVI last week (0309-0313)?
Weekly Report · 03/16 09:23
Weekly Report: what happened at MRVI last week (0302-0306)?
Weekly Report · 03/09 09:24
Weekly Report: what happened at MRVI last week (0223-0227)?
Weekly Report · 03/02 09:24
Maravai Lifesciences Charts Early Turnaround in 2025
TipRanks · 03/01 00:26
Maravai Lifesciences Holdings (MRVI) Receives a Buy from Stifel Nicolaus
TipRanks · 02/27 17:08
Maravai LifeSciences Holdings (MRVI) Posts US$130.8m TTM Loss Challenging Margin Recovery Narratives
Simply Wall St · 02/27 01:34
Maravai targets $200M–$210M 2026 revenue as restructuring drives early EBITDA turnaround
Seeking Alpha · 02/26 22:09
More
About MRVI
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human diseases. Its segments include Nucleic Acid Production Segment and Biologics Safety Testing Segment. The Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. This segment’s business units include TriLink Discovery, TriLink GMP, Glen Research and Alphazyme. The Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. This segment’s business is comprised of Cygnus Technologies. It serves various companies, including biopharmaceutical, vaccine, diagnostics and cell and gene therapy.

Webull offers Maravai Lifesciences Holdings Inc stock information, including NASDAQ: MRVI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRVI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRVI stock methods without spending real money on the virtual paper trading platform.